SILO PHARMA, INC. Gain (Loss) on Disposition of Other Assets
SILO PHARMA, INC. (SILO) reported Gain (Loss) on Disposition of Other Assets of $1.55 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-24.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2023-03-24
- SILO PHARMA, INC. gain (loss) on disposition of other assets for the quarter ending 2021-12-31 was $0.00.
- SILO PHARMA, INC. gain (loss) on disposition of other assets for fiscal 2021 was $1.55K.
| Period end | Gain (Loss) on Disposition of Other Assets 1 month | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.55K 10-K · filed 2023-03-24 | ||
| 2021-09-30 | $1.55K 10-K · filed 2023-03-24 | $1.55K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |